Panacea Biotech to set up Rs 145 crore multi-speciality hospital at Gurgaon

02 Jun 2011 Evaluate

Panacea Biotech is foraying into healthcare infrastructure sector with its plan to set up a multi-speciality hospital at Gurgaon, near New Delhi, which is expected to be operational by September 2012.

The biotech major is setting up the hospital in a joint venture (JV) with Umkal Hospitals, where Panacea will hold 76 percent and Umkal Hospitals will hold the balance stake. The total investment would be around Rs 145 crore for the proposed 175-bed hospital and is being set up under the name 'New Rise'.

Besides, Panacea Biotec, India’s third largest biotechnology company will set up an anti-cancer facility at Baddi with a total cost of Rs 50 crore, this anti-cancer facility will be operational by end of this year. Its capacity is expected to be around 1.2 million vials annually.

Panacea Biotec is one of India’s leading research based health management companies with established research, manufacturing and marketing capabilities.

Panacea Biotec Share Price

135.10 2.60 (1.96%)
13-May-2024 15:31 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1530.00
Dr. Reddys Lab 5913.95
Cipla 1421.00
Zydus Lifesciences 993.40
Lupin 1684.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.